Literature DB >> 7024322

Intra- and extracellular alpha 1-antitrypsin in liver disease with special reference to Pi phenotype.

J Carlson, S Eriksson, I Hägerstrand.   

Abstract

In order to study the relation between intra- and extrahepatocellular alpha 1-antitrypsin (alpha 1-AT) concentrations in patients with various Pi phenotypes, a prospective series of needle liver biopsies was stained with both periodic acid-Schiff (PAS) and a specific immunoperoxidase technique to demonstrate intracellular alpha 1-AT. Concomitant blood samples from all patients were analysed for alpha 1-AT. Pi phenotypes were determined by isoelectric focusing. Non-globular intrahepatocellular alpha 1-AT can be seen in biopsies from Pi M patients with increased plasma alpha 1-AT concentrations and active liver disease. No evidence was found in this study of 250 patients (including 22 controls) for predisposition toward liver disease in any phenotypic group. PAS or immunoperoxidase staining (or both) for alpha 1-AT demonstrated characteristic globular inclusions in 11 of 15 cases having the Z allele, one case being diffusely positive and three negative. Biopsies from 3 of 207 patients with liver disease and lacking the Z allele had globular inclusions seen with both PAS and immunoperoxidase techniques. alpha 1-AT globules in absence of the Z allele are most often found in elderly patients with severe disease and high plasma alpha 1-AT concentrations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7024322      PMCID: PMC494234          DOI: 10.1136/jcp.34.9.1020

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  alpha-1 Antitrypsin phenotypes determined by isoelectric focusing of the cysteine-antitrypsin mixed disulfide in serum.

Authors:  J A Pierce; J O Jeppsson; C B Laurell
Journal:  Anal Biochem       Date:  1976-07       Impact factor: 3.365

2.  Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype).

Authors:  J Lieberman; R M Silton; C M Agliozzo; J McMahon
Journal:  Am J Clin Pathol       Date:  1975-09       Impact factor: 2.493

3.  Characterization of alpha1-antitrypsin in the inclusion bodies from the liver in alpha 1-antitrypsin deficiency.

Authors:  J O Jeppsson; C Larsson; S Eriksson
Journal:  N Engl J Med       Date:  1975-09-18       Impact factor: 91.245

4.  Liver disease in adults with alpha-1 -antitrypsin deficiency.

Authors:  N O Berg; S Eriksson
Journal:  N Engl J Med       Date:  1972-12-21       Impact factor: 91.245

5.  Letter: Alpha1-antitrypsin deficiency.

Authors:  J P Martin; R Charlionet; R Sesboüe; C Ropartz
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

6.  Liver, lung and malignant disease in heterozygous (Pi MZ) alpha1-antitrypsin deficiency.

Authors:  S Eriksson; T Moestrup; I Hägerstrand
Journal:  Acta Med Scand       Date:  1975-10

7.  alpha-1-antitrypsin deficiency in liver disease: the extent of the problem.

Authors:  R L Fisher; L Taylor; S Sherlock
Journal:  Gastroenterology       Date:  1976-10       Impact factor: 22.682

8.  Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants.

Authors:  T Sveger
Journal:  N Engl J Med       Date:  1976-06-10       Impact factor: 91.245

9.  Alpha1-antitrypsin phenotypes in chronic active liver disease and primary biliary cirrhosis.

Authors:  F Kueppers; E R Dickson; W H Summerskill
Journal:  Mayo Clin Proc       Date:  1976-05       Impact factor: 7.616

10.  Heterozygous alpha 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association.

Authors:  T Morin; J P Martin; G Feldmann; B Rueff; J P Benhamou; C Ropartz
Journal:  Lancet       Date:  1975-02-01       Impact factor: 79.321

View more
  3 in total

1.  Immunohistochemical localization of alpha 1-antitrypsin and alpha 1-antichymotrypsin in salivary pleomorphic adenomas.

Authors:  N Murase; K Kobayashi; H Mitani; M Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

2.  Multiple tissues express alpha 1-antitrypsin in transgenic mice and man.

Authors:  J A Carlson; B B Rogers; R N Sifers; H K Hawkins; M J Finegold; S L Woo
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

3.  Alpha-1-antitrypsin and the liver: a routine immunohistological screen.

Authors:  J M Theaker; K A Fleming
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.